Effects of Denosumab and Calcitriol on Severe Secondary Hyperparathyroidism in Dialysis Patients with Low Bone Mass (original) (raw)
Severe Symptomatic Hypocalcemia after Denosumab Administration in an End-Stage Renal Disease Patient on Peritoneal Dialysis with Controlled Secondary Hyperparathyroidism
Mihály Tapolyai
British Journal of Medicine and Medical Research, 2013
View PDFchevron_right
Denosumab for Osteoporosis in Patients With Primary Hyperparathyroidism and Renal Insufficiency
Zhanna Belaya
Research Square (Research Square), 2022
View PDFchevron_right
Efficacy of antiresorptive agents bisphosphonates and denosumab in mitigating hypercalcemia and bone loss in primary hyperparathyroidism: A systematic review and meta-analysis
Ambrish Mithal
Frontiers in Endocrinology, 2023
View PDFchevron_right
Effects of calcitriol on parathyroid function and on bone remodelling in secondary hyperparathyroidism
Maria Moyses
Nephrology Dialysis Transplantation, 2003
View PDFchevron_right
Comparison between Calcitriol and Calcitriol Plus Low-Dose Cinacalcet for the Treatment of Moderate to Severe Secondary Hyperparathyroidism in Chronic Dialysis Patients
chien-te lee
Nutrients, 2013
View PDFchevron_right
Low-dose intravenous calcitriol treatment of secondary hyperparathyroidism in hemodialysis patients
Diego Brancaccio
Kidney International, 1992
View PDFchevron_right
Treatment of Secondary Hyperparathyroidism in Maintenance Hemodialysis Patients by Intravenous Calcitriol
aquiles jara
Seminars in Dialysis, 1994
View PDFchevron_right
Long-term effects of intravenous calcitriol therapy on the control of secondary hyperparathyroidism
Daniele Marcelli
American Journal of Kidney Diseases, 1996
View PDFchevron_right
Beneficial role of intravenous calcitriol on bone mineral density in children with severe secondary hyperparathyroidism
Ali Duzova
International Urology and Nephrology, 2000
View PDFchevron_right
Changes in bone turnover after parathyroidectomy in dialysis patients: role of calcitriol administration
Francesco Zaraca
Nephrology Dialysis Transplantation, 2000
View PDFchevron_right
Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy
Jorge Ramirez
Kidney International, 1994
View PDFchevron_right
D. Brancaccio, M. Cozzolino, G. Cannella, P. Messa, M. Bonomimi, G. Cancarini, MR. Caruso, C. Cascone, AM Costanzo, M. Salvadori; FARO Study Group Secondary Hyperparathyroidism in Chronic Dialysis Patients: Results of the Italian FARO Survey on Treatment and Mortality. Blood Purif. 32: 124-32, 2011
Diego Brancaccio
Blood Purification
View PDFchevron_right
Nephrology picture: bone loss due to absence of adequate therapy for severe secondary hyperparathyroidism
Rosilene Elias
Journal of Nephrology, 2022
View PDFchevron_right
Denosumab associated with bone density increase and clinical improvement in a long-term hemodialysis patient. Case report and review of the literature
Vladimir Palicka
Acta medica (Hradec Králové) / Universitas Carolina, Facultas Medica Hradec Králové, 2014
View PDFchevron_right
Contrasting PTH Response of Denosumab Use in Dialysis Patients: A Report of 2 Cases
Soo Min Jang
Pharmacy, 2020
View PDFchevron_right
A Slight Decrease in Renal Function Further Impairs Bone Mineral Density in Primary Hyperparathyroidism
A. Piovesan
The Journal of Clinical Endocrinology & Metabolism, 2006
View PDFchevron_right
Usefulness and pharmacokinetics of subcutaneous calcitriol in the treatment of secondary hyperparathyroidism
Jose Vicente Torregrosa
Nephrology Dialysis Transplantation, 1996
View PDFchevron_right
Evidence of healing of secondary hyperparathyroidism in chronically hemodialyzed uremic patients treated with long-term intravenous calcitriol
Giuseppe Cannella
Kidney International, 1994
View PDFchevron_right
Hyperparathyroidism in the hemodialysis population: A survey of 612 patients
Mahmoud Salem
American Journal of Kidney Diseases, 1997
View PDFchevron_right
Effect of administering calcium carbonate to treat secondary hyperparathyroidism in nondialyzed patients with chronic renal failure
Yusuke Tsukamoto
American Journal of Kidney Diseases, 1995
View PDFchevron_right
Pharmacological Management of Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease
Martin Wilkie
Drugs, 2016
View PDFchevron_right
Treatment of Secondary Hyperparathyroidism With Low Dose Intermittent Calcitriol in Hemodialysis Patients
Domenico Laganà
ASAIO Journal, 1995
View PDFchevron_right
Management of Secondary Hyperparathyroidism: The Importance and the Challenge of Controlling Parathyroid Hormone Levels without Elevating Calcium, Phosphorus, and Calcium-Phosphorus Product
Emanuel Zitt
American Journal of Nephrology, 2003
View PDFchevron_right
Management of Secondary Hyperparathyroidism in Hemodialysis Patients
Ulrich Neyer
InTech eBooks, 2011
View PDFchevron_right
The importance of dosing intravenous calcitriol in dialysis patients with severe hyperparathyroidism
Jose Hervás
American Journal of Kidney Diseases, 1995
View PDFchevron_right